Johnson & Johnson (JNJ)
158.24
-1.89
(-1.18%)
USD |
NYSE |
Nov 04, 16:00
158.48
+0.24
(+0.15%)
Pre-Market: 04:30
Johnson & Johnson Net Income (Annual): 35.15B for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 35.15B |
December 31, 2022 | 17.94B |
December 31, 2021 | 20.88B |
December 31, 2020 | 14.71B |
December 31, 2019 | 15.12B |
December 31, 2018 | 15.30B |
December 31, 2017 | 1.30B |
December 31, 2016 | 16.54B |
December 31, 2015 | 15.41B |
December 31, 2014 | 16.32B |
December 31, 2013 | 13.83B |
December 31, 2012 | 10.85B |
December 31, 2011 | 9.672B |
December 31, 2010 | 13.33B |
December 31, 2009 | 12.27B |
December 31, 2008 | 12.95B |
December 31, 2007 | 10.58B |
December 31, 2006 | 11.05B |
December 31, 2005 | 10.06B |
December 31, 2004 | 8.18B |
Date | Value |
---|---|
December 31, 2003 | 7.197B |
December 31, 2002 | 6.597B |
December 31, 2001 | 5.668B |
December 31, 2000 | 4.953B |
December 31, 1999 | 4.273B |
December 31, 1998 | 3.003B |
December 31, 1997 | 3.303B |
December 31, 1996 | 2.887B |
December 31, 1995 | 2.403B |
December 31, 1994 | 2.006B |
December 31, 1993 | 1.787B |
December 31, 1992 | 1.03B |
December 31, 1991 | 1.461B |
December 31, 1990 | 1.143B |
December 31, 1989 | 1.082B |
December 31, 1988 | 974.00M |
December 31, 1987 | 833.00M |
December 31, 1986 | 329.50M |
December 31, 1985 | 613.70M |
December 31, 1984 | 514.50M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
14.71B
Minimum
2020
35.15B
Maximum
2023
20.76B
Average
17.94B
Median
2022
Net Income (Annual) Benchmarks
Amgen Inc | 6.717B |
Eli Lilly and Co | 5.240B |
Merck & Co Inc | 365.00M |
Pfizer Inc | 2.119B |
AbbVie Inc | 4.863B |